- Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
-
Sungkeun Kim, Hee Yeon Kim, Su Lim Lee, Young Mi Ku, Yoo Dong Won, Chang Wook Kim
-
J Liver Cancer. 2020;20(1):60-66. Published online March 31, 2020
-
DOI: https://doi.org/10.17998/jlc.20.1.60
-
-
5,104
Views
-
140
Downloads
-
1
Citation
-
Abstract
PDF
- Transcatheter arterial chemoembolization (TACE) is a useful palliative therapeutic modality for hepatocellular carcinoma (HCC). Postembolization syndromes, such as fever, abdominal pain, and elevated liver enzyme levels are commonly known complications of TACE. One post-TACE pulmonary complication, lipiodol pneumonitis, is rarely reported. Lipiodol pneumonitis after TACE appears to be associated with chemical injury due to accidental perfusion of lipiodol to the lung vasculature, promoted by arteriovenous shunts within the hypervascular HCC. Here, we report a 42-year-old man with unresectable HCC and hepatic vein thrombosis. The patient was initially treated with TACE. The following day after TACE, acute respiratory symptoms such as dyspnea and cough developed with decreased oxygen saturation. Chest X-ray and computed tomography showed multiple patches and diffuse ground-glass opacities in both lung fields, suggesting of lipiodol pneumonitis. The patient’s condition and radiologic abnormalities subsequently improved after 2 weeks of conservative treatment alone.
-
Citations
Citations to this article as recorded by
- Lipiodol-induced Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Heechul Nam The Korean Journal of Gastroenterology.2022; 80(5): 233. CrossRef
- Metastatic Liver Cancer Mimicking Hepatocellular Carcinoma in Alcoholic Cirrhosis
-
Hee Yeon Kim, Chang Wook Kim, Chang Don Lee, Su Lim Lee, Yoo Dong Won, Ye Il Kim
-
Journal of the Korean Liver Cancer Study Group. 2014;14(1):41-45. Published online March 31, 2014
-
DOI: https://doi.org/10.17998/jlc.14.1.41
-
-
Abstract
PDF
- A 50-year-old male patient visited for further evaluation of arterial enhancing nodules in
cirrhotic liver. Computed tomography (CT) scan revealed vaguely nodular, arterial phaseenhancing
nodules at segment 8 of the liver with cirrhotic background. Magnetic resonance
imaging (MRI) showed four small nodules with early work-up enhancement in arterial phase
and rapid washout. Angiography showed hypervascular nodular stains. Hepatocellular
carcinoma (HCC) was diagnosed according to the noninvasive diagnostic criteria for HCC.
A positron emission tomography (PET) scan was done for staging work-up, and increased
uptake was noted in rectum. Subsequently, sigmoidoscopy revealed an ulceroinfiltrative
lesion encircling the lumen of the rectosigmoid junction. Laparoscopic low anterior resection
with wedge resection of liver was done, suspecting concurrent primary tumors of the rectum
and liver. Pathologic examination demonstrated moderately differentiated adenocarcinoma
in both rectum and liver, suggesting metastatic rectal carcinoma. The present case indicates
that metastatic carcinoma as well as HCC should be considered in the differential diagnosis of
irregularly enhancing small nodules even in high-risk patient group for HCC.
- A Case of Hepatocellular Carcinoma with Bile Duct Invasion Treated with Transarterial Chemoembolization
-
Hee Yeon Kim, Chang Wook Kim, Chang Don Lee, Soo Lim Lee, Yoo Dong Won, Ye Il Kim
-
Journal of the Korean Liver Cancer Study Group. 2013;13(2):158-163. Published online September 30, 2013
-
DOI: https://doi.org/10.17998/jlc.13.2.158
-
-
Abstract
PDF
- A 53-year-old female patient visited our hospital complaining of intermittent right upper quadrant pain for 6 months. Computed tomography (CT) scan revealed an irregular shaped tumor at segment 4 of the liver with biliary tumor thrombi extending into the common bile duct. Percutaneous transhepatic biliary drainage was done for decompression of bile duct dilatation. The patient underwent 6 sessions of transarterial chemoembolization (TACE). Partial response was obtained shortly after TACE. However, regrowth of intraductal tumor resulted in an obstructive jaundice. After a slight decompression of the obstructive jaundice, the patient underwent TACE. Jaundice temporarily worsened following the TACE, but improved, and follow-up CT demonstrated some shrinkage of the intraductal mass. This case indicates that obstructive-type jaundice may not be a contraindication for TACE, and aggressive TACE may improve prognoses of patients with hepatocellular carcinoma and biliary tumor thrombi.
- A Case of Combination Therapy Using Radioembolization and Transarterial Chemoembolization with Drug-eluting Beads in Bilobar Hepatocellular Carcinomas
-
Hee Yeon Kim, Chung-Hwa Park, Do Seon Song, Myeong Jun Song, Jong Young Choi, Seung Kew Yoon, Si Hyun Bae, Ho Jung Chun
-
Journal of the Korean Liver Cancer Study Group. 2012;12(2):128-132. Published online September 30, 2012
-
-
-
Abstract
PDF
- Bilobar multifocal hepatocellular carcinomas (HCCs) can be treated with transarterial radioembolization in a sequential lobar, or whole liver manner. However, radioembolization could result in a risk of radiation-induced liver toxicity in patients with reduced functional reserve. Here we describe a case with bilobar HCCs successfully treated with a combination therapy using radioembolization and transarterial chemoembolization with drug-eluting beads without significant side effects. A 72-year-old female with liver cirrhosis was diagnosed of hepatocellular carcinoma with bilobar involvement. The main mass in the left lobe was treated with radioembolization while the other lesion in the right lobe was treated with transarterial chemoembolization using drug-eluting beads, and the patient was tolerable. A combination of radioembolization and selective transarterial chemoem- bolization may be considered for an alternative option in patients with bilobar multifocal HCCs with decreased liver function.
- A Case of Hepatocellular Carcinoma which Showed Response to Transarterial Chemoembolization with DC Bead® in the Patient who Showed No Response to Conventional Transarterial Chemoembolization
-
Do Seon Song, Hee Yeon Kim, Myeong Jun Song, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Ho Jong Chun
-
Journal of the Korean Liver Cancer Study Group. 2012;12(2):133-136. Published online September 30, 2012
-
-
-
Abstract
PDF
- Hepatocellular carcinoma (HCC) is one of the most important cause of cancer death in South Korea. Approximately two thirds
of the HCC patients are diagnosed in the unresectable stage. Conventional transarterial chemoembolization (TACE) showed
survival benefit in the unresectable HCC patients, but it had some limitations, such as low response rate and systemic toxicity.
Drug eluting bead has been reported low systemic toxicity and higher tumor necrosis rate. We report a case which showed
response to TACE with DC bead in patient that showed no response to conventional TACE.
- A Case of Hepatocellular Carcinoma in a 10 Year Old Child Treated with Yttrium Radioembolization and Transarterial Chemoembolization
-
Sung Won Lee, Hee Yeon Kim, Do Seon Song, Chung-Hwa Park, Myeong Jun Song, Jong Young Choi, Seung Kew Yoon, Jung Suk Oh, Ho Jong Chun, Si Hyun Bae
-
Journal of the Korean Liver Cancer Study Group. 2012;12(2):137-140. Published online September 30, 2012
-
-
-
Abstract
PDF
- Hepatocellular carcinoma (HCC) in childhood is rare but is the second most common malignant liver neoplasm after
hepatoblastoma in children. Surgical resectability is the foundation of curative therapy but only one third of newly diagnosed
HCCs are resectable, and unresectable HCC remains largely unresponsive to systemic chemotherapy. In all reported series of
HCC in children, therapeutic results are poor with overall survival less than 30%. Systemic chemotherapy is only partially
effective but if preoperative downstaging can be achieved, it would result in a higher survival rate. There are scarce data
regarding local ablative treatments such as transarterial chemoembolization (TACE) and therefore survival benefits are still
unclear. TACE may be considered as a therapeutic alternative in cases of unresectable tumors after systemic chemotherapy or in
unresectable, non-metastatic HCCs. The use of orthotopic liver transplantation in childhood HCC remains controversial.
Radioembolization is a mode of treatment that aims to selectively target radiation to all liver tumors using yttrium-90
microspheres while limiting the dose to normal liver parenchyma. It may be considered as another treatment option in childhood
HCC with the purpose of preoperative downstaging but further studies are required to determine the treatment benefits and safety
of radioembolization treatment.
- A Case of Progressive Superior Mesenteric Vein Thrombosis after Percutaneous Transhepatic Obliteration in Infiltrative Hepatocellular Carcinomaswith Portal Vein Thrombosis
-
Hee Yeon Kim, Chung-Hwa Park, Sung won Lee, Do Seon Song, Myeong Jun Song, Jong Young Choi, Seung Kew Yoon, Si Hyun Bae, Jung Suk Oh, Ho Jong Chun
-
Journal of the Korean Liver Cancer Study Group. 2012;12(2):146-150. Published online September 30, 2012
-
-
-
Abstract
PDF
- Percutaneous transhepatic obliteration of gastroesophageal varices is one of the effective emergency procedure when
endoscopic therapy is not indicated or has been failed. One of the major complications of this procedure is portal thrombosis. A
53-year-old male with hepatitis B virus infection was diagnosed of infiltrative hepatocellular carcinoma with right portal vein
thrombosis. On the next day after being hospitalization, the patient developed variceal bleeding. With medical management,
endoscopic therapy was initially attempted, however, it ended in failure. Emergency percutaneous transhepatic obliteration of
bleeding gastroesophageal varices was considered as a next option. Bleeding from gastroesophageal varices was stopped after
percutaneous obliateration, however, portal thrombosis was extended to splenic vein or superior mesenteric veins.
- Conus Medullaris Syndrome after Transcatheter Arterial Chemoembolization in Patient with Hepatocellular Carcinoma
-
Sun Hong Yoo, Si Hyun Bae, Pil Soo Sung, Hee Yeon Kim, Do Seon Song, Myeong Jun Song, Jong Young Choi, Seung Kew Yoon, Ho Jong Chun
-
Journal of the Korean Liver Cancer Study Group. 2011;11(2):185-189. Published online September 30, 2011
-
-
-
Abstract
PDF
- Hepatocellular carcinoma (HCC) is the fourth most common cancer in Korea and a common cause of cancer death.
Transcatheter arterial chemoembolization (TACE) is used as palliative therapy for patients with inoperable HCC. TACE is an
effective treatments for inoperable HCC, but variable complications due to using embolic agents can occur after TACE.
Complications due to embolic agents include pulmonary lipiodol embolism, splenic infarction, cerebral lipiodol infarction, and
spinal cord injury. This is a rare case of spinal cord injury after a sixth TACE via right T9 intercostal artery.
- Hepatocellular Carcinoma Diagnosed with Metastatic Lesion of the Cervical Spine
-
Chung-Hwa Park, Myeong Jun Song, Hee Yeon Kim, Si Hyun Bae, Seung Kew Yoon, Jong Young Choi
-
Journal of the Korean Liver Cancer Study Group. 2010;10(1):61-63. Published online June 30, 2010
-
-
-
Abstract
PDF
- Bone metastases in hepatocellular carcinoma (HCC) are usually treated with non-operative procedures such as radiotherapy,
hormonal therapy, bisphosphonates, or sometimes with surgical procedures. Here we describe a case with 3rd cervical spine
metastasis of HCC. A 62-year-old female with liver cirrhosis presented with neck pain. After evaluation, the patient was
diagnosed of hepatocellular carcinoma with cervical spine metastasis. The metastatic lesion was treated with tomotherapy
while the primary lesion in the liver was treated with transarterial chemoembolization using drug-eluting beads, and the
patient is tolerable waiting for the next treatment.
|